Product Information
QBRELIS 1 MG/ML SOLUTION is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $4.4954 per ML under NDC 52652300101. Its NADAC has been published 205 times since Sep 21, 2022.
FDA first approved this application on Jul 29, 2016.
The High Outlier badge above means this manufacturer's average price in the lisinopril market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/mL
Manufacturer
Azurity Pharmaceuticals Inc.NDC
52652300101
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LISINOPRILApproval Type
New Drug (NDA)
FDA Application
NDA208401FDA Approved
7/29/2016
On Market Since
8/29/2016
Pharmacological Classes
Price Statistics
The NADAC for QBRELIS 1 MG/ML SOLUTION has been published 205 times since Sep 21, 2022, and over the history we have for it it has risen 31.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4954 per ML |
|---|---|
| All-time high | $4.4954 (Aug 19, 2026) |
| All-time low | $3.4237 (Sep 21, 2022) |
| 52-week high | $4.4954 |
| 52-week low | $4.3447 |
| Median price | $4.0365 |
| Average price | $4.0679 |
| Largest weekly change | +9.8% (Jan 4, 2023) |
| Weeks tracked | 205 |
| Tracking since | Sep 21, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lisinopril market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QBRELIS 1 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for QBRELIS 1 MG/ML SOLUTION, manufactured by Azurity Pharmaceuticals Inc., is $4.4954 per ML (NDC 52652300101), effective Aug 19, 2026.
How has the price of QBRELIS 1 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for QBRELIS 1 MG/ML SOLUTION has risen 31.3%. It has been tracked across 205 weekly CMS publications since Sep 21, 2022.
What are the highest and lowest recorded NADAC prices for QBRELIS 1 MG/ML SOLUTION?
Since Sep 21, 2022, the NADAC for QBRELIS 1 MG/ML SOLUTION has ranged from a low of $3.4237 (Sep 21, 2022) to a high of $4.4954 (Aug 19, 2026), with a median of $4.0365 per ML.
Are there cheaper alternatives to QBRELIS 1 MG/ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of QBRELIS 1 MG/ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QBRELIS 1 MG/ML SOLUTION?
QBRELIS 1 MG/ML SOLUTION (NDC 52652300101) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.